*Applications will be reviewed on a rolling-basis.
Two research opportunities are currently available in the Office of Biostatistics and Epidemiology (OBE) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
The selected participant will be involved in the development of quantitative models to simulate and predict human immune responses to biologics such as vaccines and cancer immunotherapies. The end goal of this project is the development of computational tools to enhance efficacy and safety evaluation of vaccines, current and next-generation of engineered therapeutic products, leading to personalized and optimal treatment regimens for patients. Under the guidance of a mentor, the participant will develop and apply novel techniques to model and simulate interactive cellular and molecular components of human immune system. The activities include literature reviews, data collection/curation, model development, presentation of research results, and preparation of scientific manuscripts.
Anticipated Appointment Start Date: December 2021; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity in your email (FDA-CBER-2021-0041).